FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries buPROPion Hydrochloride Extended-release Recall

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class III
Reported by FDA
Oct 12, 2016
Recall ID
D-0007-2017
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled buPROPion Hydrochloride Extended-release starting Sep 13, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0007-2017 on Oct 12, 2016. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceuticals Ind. Ltd. Halol- Baroda Highway, Halol-389 350, Gujarat, India. UPC 347335737868 NDC 47335-737-86

Lot numbers, UPCs & expiration codes

JKN5124A and JKN5229A, exp 10/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0007-2017
Classification
Class III
Status
Terminated
Recall initiated
Sep 13, 2016
FDA report date
Oct 12, 2016
Quantity
31,762 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0007-2017, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
75206
Address
270 Prospect Plains Rd
Code information
JKN5124A and JKN5229A, exp 10/2016
Postal code
08512-3605
Report date
Oct 12, 2016
Product type
Drugs
Recall number
D-0007-2017
Classification
Class III
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
31,762 bottles
Termination date
Jul 2, 2018
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceuticals Ind. Ltd. Halol- Baroda Highway, Halol-389 350, Gujarat, India. UPC 347335737868 NDC 47335-737-86
Distribution pattern
Nationwide
Recall initiation date
Sep 13, 2016
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Oct 6, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0007-2017, published Oct 12, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls